KRIBIOLISA™ Mosunetuzumab ELISA
KRISHGEN BioSystemsELISA for the detection of Mosunetuzumab in human serum and plasma.
Enzyme-linked immunosorbent assays (ELISA), also known as enzyme immunoassays (EIA), are used for the detection and quantification of proteins, peptides and antibodies in a sample. ELISA often comes in kit format, with pre-selected antibody pairs to detect specific proteins or biomarkers of diseases such as diabetes and obesity, or cardiovascular and neurological disorders. Detection is made possible with chemiluminescent, fluorescent or colorimetric substrates and detection instruments such as microplate / ELISA readers. Other kits available include: Enzyme-linked immunospot (ELISPOT) assays for the quantification of protein-producing cells and chemiluminescent immunoassays (CLIA) kits. Find the best ELISA kits and products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.
ELISA for the detection of Mosunetuzumab in human serum and plasma.
Enzyme Immunoassay for the Quantitative Determination of Darbepoetin in human serum and plasma
Enzyme Immunoassay for the quantitative determination of Nilotinib in serum, plasma and cell culture supernatant
Enzyme Immunoassay for the Quantitative Determination of Dasatinib in human serum and plasma
Enzyme Immunoassay for the quantitative determination of Golimumab in serum, plasma and cell culture supernatant
Enzyme Immunoassay for the quantitative determination of Necitumumab in serum and plasma.
Immunoassay for quantitative estimation of Cafilzomib in human serum and plasma.
Immunoassay for the quantitative determination of Ustekinumab in human serum and plasma
Enzyme Immunoassay for the quantitative determination of Denosumab (PROLIA) in serum, plasma and cell culture supernatant
Enzyme Immunoassay for the quantitative determination of Vedolizumab (ENTYVIO) in serum, plasma and cell culture supernatant
The Eculizumab (Soliris) ELISA kit is intended for the quantitative determination of Eculizumab (Soliris) in serum, plasma and cell culture samples. CE IVD marked. Key features: -uses highly specific monoclonal anti-idiotypic antibodies -calibrator used is commerically available eculizumab injection itself -Recovery: 80-120% -Precision CV
Enzyme Immunoassay for the quantitative determination of Ixekizumab in serum and plasma.
Enzyme Immunoassay for the quantitative determination of Secukinumab in serum and plasma.
Enzyme Immunoassay for the quantitative determination of Sunitinib in serum, plasma and cell culture supernatant
ELISA for the detection of Catumaxomab in human serum and plasma. Lead time for this kit is 5 weeks. About the kit: - Uses anti-idiotypic monoclonal antibodies sourced from our vendor partner in the US, which ensures higher specificity, and low cross reactivity. - Recovery rates are between 85 - 115% - Validated as per US FDA guidelines for Bioassays - Developed using the innovator drug as calibrator - Shelf life: 1 year
Enzyme Immunoassay for the Quantitative Determination of Emicizumab in human Serum and Plasma
ELISA for the detection of Glofitamab in human serum and plasma. Lead time for this kit is 5 weeks. About the kit: - Uses anti-idiotypic monoclonal antibodies sourced from our vendor partner in the US, which ensures higher specificity, and low cross reactivity. - Recovery rates are between 85 - 115% - Validated as per US FDA guidelines for Bioassays - Developed using the innovator drug as calibrator - Shelf life: 1 year
ELISA for the detection of Epcoritamab in human serum and plasma. Lead time for this kit is 5 weeks. About the kit: - Uses anti-idiotypic monoclonal antibodies sourced from our vendor partner in the US, which ensures higher specificity, and low cross reactivity. - Recovery rates are between 85 - 115% - Validated as per US FDA guidelines for Bioassays - Developed using the innovator drug as calibrator - Shelf life: 1 year
Immunoassay for quantitative determination of P. pastoris Host Cell Proteins
Enzyme Immunoassay for the Quantitative Determination of HEK HCP in human serum, plasma and other biological samples.
Robust and Sensitive Enzyme Immunoassay for the detection of CRM197 in biological preparations including vaccines and cell culture supernatants. Standard used is CRM197 expressed in E.coli.
The Etanercept (Enbrel) ELISA kit is intended for the quantitative determination of Etanercept (Enbrel) in serum, plasma and cell culture samples.
Enzyme Immunoassay for quantitative detection of Anti-Darbepoetin in serum and plasma.
Immunoassay for quantitative estimation of Lixisenatide in human serum, plasma and tissue extracts.
Immunoassay for quantitative estimation of Triptorelin in human serum, plasma and tissue extracts.